These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2773791)

  • 1. Effect of selective intracoronary antiarrhythmic drug administration in sustained ventricular tachycardia.
    Friedman PL; Selwyn AP; Edelman E; Wang PJ
    Am J Cardiol; 1989 Sep; 64(8):475-80. PubMed ID: 2773791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia.
    Kay GN; Epstein AE; Bubien RS; Anderson PG; Dailey SM; Plumb VJ
    J Am Coll Cardiol; 1992 Jan; 19(1):159-68. PubMed ID: 1729328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
    Gorgels AP; van den Dool A; Hofs A; Mulleneers R; Smeets JL; Vos MA; Wellens HJ
    Am J Cardiol; 1996 Jul; 78(1):43-6. PubMed ID: 8712116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia.
    Komura S; Chinushi M; Furushima H; Hosaka Y; Izumi D; Iijima K; Watanabe H; Yagihara N; Aizawa Y
    Circ J; 2010 May; 74(5):864-9. PubMed ID: 20339190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method for evaluating the effects of antiarrhythmic drugs on ventricular tachycardias with different electrophysiologic characteristics and different mechanisms in the infarcted canine heart.
    Davis J; Glassman R; Wit AL
    Am J Cardiol; 1982 Apr; 49(5):1176-84. PubMed ID: 7064843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Keefe D; Miura DS
    Am J Cardiol; 1984 Aug; 54(4):37B-42B. PubMed ID: 6465045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y; Chinushi M; Naitoh N; Shibata A
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.
    Steinbeck G; Andresen D; Bach P; Haberl R; Oeff M; Hoffmann E; von Leitner ER
    N Engl J Med; 1992 Oct; 327(14):987-92. PubMed ID: 1355595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intracoronary lidocaine infusion on acetylstrophanthidin-induced ventricular arrhythmia in dogs.
    Tordjman T; Lampert S; Lown B
    Pharmacotherapy; 1988; 8(2):89-93. PubMed ID: 3399425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Tepper D; Maguire W; Willens H; Keren G; Miura D
    Am J Cardiol; 1984 Aug; 54(4):49B-54B. PubMed ID: 6465047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of quinetholate, lidocaine and procainamide on ouabain-induced ventricular tachycardia and cardiac function.
    Taylor SE; Nash CB
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):279-90. PubMed ID: 677962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intracoronary lidocaine on ventricular arrhythmia in the infarcted canine heart.
    Tordjman T; Raeder E; Lampert S; Lown B
    Pharmacotherapy; 1988; 8(5):295-8. PubMed ID: 3252195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of incessant polymorphic ventricular tachycardia by selective intracoronary ethanol infusion.
    Okishige K; Andrews TC; Friedman PL
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 1):188-95. PubMed ID: 1706504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes.
    Bhandari AK; Au PK; Rahimtoola SH
    Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.